Skip to content

Evaluation of Perioperative Cardiovascular Risk in Patients with Brain-Heart Comorbidity Using Riganosin Stress Echocardiography: A Prospective Cohort Study

Evaluation of Perioperative Cardiovascular Risk in Patients with Brain-Heart Comorbidity Using Riganosin Stress Echocardiography: A Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123611
Enrollment
Unknown
Registered
2026-04-28
Start date
2026-04-28
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain-heart co-occurring diseases

Interventions

High-Risk Group for Riganosin Stress Echocardiography:None
Low-Risk Group for Riganosin Stress Echocardiography:None

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 45–80 years; 2. Meet the criteria for "high-risk patients with coexisting cerebrovascular and cardiovascular disease" (must satisfy all 3 criteria): (1) Cardiovascular disease: 1) Coronary artery disease (history of myocardial infarction >3 months, PCI, or CABG) or ST-T changes on resting ECG + positive exercise test; 2) Borderline cardiac function (LVEF 40%–50% or NT-proBNP 200–1,000 pg/mL); (2) Cerebrovascular disease: 1) Ischemic stroke/TIA > 3 months (mRS = 70% (asymptomatic); (3) Diabetes; (4) Cerebral small vessel disease (e.g., lacunar infarction); (5) Surgical risk: Elective non-cardiac surgery (carotid endarterectomy/major abdominal surgery/orthopedic/urological/thoracic surgery) expected to last >1 hour 3. ASA classification II–IV; 4. Undergo Riganosin stress echocardiography; 5. Sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Data unavailable; 2. Unable to complete follow-up.

Design outcomes

Primary

MeasureTime frame
major adverse cardiovascular and cerebral events (MACCE) at 30 days post-surgery;

Secondary

MeasureTime frame
myocardial injury after non-cardiac surgery (MINS);

Countries

China

Contacts

Public ContactYu Yun

Beijing Tiantan Hospital, Capital Medical University

yy_waitou@163.com+86 138 1148 9180

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026